Bcl-2 family protein inhibitors induce a unique thrombocytopenia in vivo.

被引：1
|
作者：
Elmore, Steven W. [1 ]
Bauch, Joy [1 ]
Fryer, Ryan M. [1 ]
Iciek, Laurie [1 ]
Marsh, Kennan [1 ]
Morgan, Sherry J. [1 ]
Nelson, Richard [1 ]
Reinhart, Glenn A. [1 ]
Smith, Morey L. [1 ]
Tse, Chris [1 ]
Rosenberg, Saul H. [1 ]
机构：
[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.4236.4236
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4236
引用
收藏
页码：138B / 138B
页数：1
相关论文
共 50 条
  • [21] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [22] Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family
    Krajewski, S
    Krajewska, M
    Reed, JC
    CANCER RESEARCH, 1996, 56 (12) : 2849 - 2855
  • [23] The Role of the Acidity of N-Heteroaryl Sulfonamides as Inhibitors of Bcl-2 Family Protein-Protein Interactions
    Toure, B. Barry
    Miller-Moslin, Karen
    Yusuff, Naeem
    Perez, Lawrence
    Dore, Michael
    Joud, Carol
    Michael, Walter
    DiPietro, Lucian
    van der Plas, Simon
    McEwan, Michael
    Lenoir, Francois
    Hoe, Madelene
    Karki, Rajesh
    Springer, Clayton
    Sullivan, John
    Levine, Kymberly
    Fiorilla, Catherine
    Xie, Xiaoling
    Kulathila, Raviraj
    Herlihy, Kara
    Porter, Dale
    Visser, Michael
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (02): : 186 - 190
  • [24] Small molecule inhibitors of protein-protein interactions: Targeting Bcl-2 family proteins to treat cancer
    Elmore, Steven W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [25] Modulation of synaptic transmission by the BCL-2 family protein BCL-xL
    Jonas, EA
    Hoit, D
    Hickman, JA
    Brandt, TA
    Polster, BM
    Fannjiang, Y
    McCarthy, E
    Montanez, MK
    Hardwick, JM
    Kaczmarek, LK
    JOURNAL OF NEUROSCIENCE, 2003, 23 (23): : 8423 - 8431
  • [26] Cytoskeleton inhibitors combined with TRAIL induce apoptosis in HeLa carcinoma cells overexpressing antiapoptotic protein Bcl-2
    M. E. Gasparian
    L. V. Domnina
    O. Yu. Ivanova
    D. S. Izyumov
    A. Yu. Lomakin
    E. N. Popova
    A. V. Yagolovich
    O. Yu. Pletjushkina
    D. A. Dolgikh
    B. V. Chernyak
    Biochemistry (Moscow), 2008, 73 : 358 - 362
  • [27] Resistance to BCL-2 Inhibitors
    Tam, Constantine S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S78 - S79
  • [28] Cytoskeleton inhibitors combined with TRAIL induce apoptosis in HeLa carcinoma cells overexpressing antiapoptotic protein bcl-2
    Gasparian, M. E.
    Domnina, L. V.
    Ivanova, O. Yu.
    Izyumov, D. S.
    Lomakin, A. Yu.
    Popova, E. N.
    Yagolovich, A. V.
    Pletjushkina, O. Yu.
    Dolgikh, D. A.
    Chernyak, B. V.
    BIOCHEMISTRY-MOSCOW, 2008, 73 (03) : 358 - 362
  • [29] RAPLINK-1 COOPERATES WITH INHIBITORS OF BCL-2/BCL-XL TO INDUCE APOPTOSIS IN GLIOBLASTOMA
    Luo, Xujun
    Fan, Qi-Wen
    Shokat, Kevan M.
    Weiss, William A.
    NEURO-ONCOLOGY, 2019, 21 : 115 - 115
  • [30] Inhibitors of Bcl-2 protein family deplete ER Ca2+ stores in pancreatic acinar cells
    Gerasimenko, Julia
    Ferdek, Pawel
    Fischer, Lars
    Gukovskaya, Anna S.
    Pandol, Stephen J.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2010, 460 (05): : 891 - 900
12345